A case series of 20 women with hidradenitis suppurativa treated with spironolactone

Australasian Journal of Dermatology

Volumn 56, Issue 3, 2015, Pages 192-196

  Lee, Andrew ^a,b   Fischer, Gayle ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

anti androgen; hidradenitis suppurativa; spironolactone

Indexed keywords

SPIRONOLACTONE; ANTIANDROGEN;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLEARANCE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERKALEMIA; MENSTRUAL IRREGULARITY; MIDDLE AGED; MOOD CHANGE; PATIENT SATISFACTION; RETROSPECTIVE STUDY; SUPPURATIVE HIDRADENITIS; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT; HIDRADENITIS SUPPURATIVA; YOUNG ADULT;

ADOLESCENT; ADULT; ANDROGEN ANTAGONISTS; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; SPIRONOLACTONE; YOUNG ADULT;

EID: 84937523131     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/ajd.12362     Document Type: Article

References (16)

1. Alikhan A, Lynch PJ, Eisen DB,. Hidradenitis suppurativa: a comprehensive review. J. Am. Acad. Dermatol. 2009; 60: 539-561.
2. Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp. Dermatol. 2008; 17: 455-456.
3. Lasocki A, Sinclair R, Foley P, et al. Hidradenitis suppurativa responding to treatment with infliximab. Australas. J. Dermatol. 2010; 51: 186-190.
4. Miller I, Lynggaard CD, Lophaven S, et al. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br. J. Dermatol. 2011; 165: 391-398.
5. Kraft JN, Searles GE,. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J. Cutan. Med. Surg. 2007; 11: 125-131.
6. Joseph MA, Jayaseelan E, Ganapathi B, et al. Hidradenitis suppurativa treated with finasteride. J. Dermatolog. Treat. 2005; 16: 75-78.
7. Mortimer PS, Dawber RP, Gales MA, et al. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br. J. Dermatol. 1986; 115: 263-268.
8. Sawers RS, Randall VA, Ebling FJ,. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy. Br. J. Dermatol. 1986; 115: 269-274.
9. Kimball AB, Kerdel F, Adams D, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann. Intern. Med. 2012; 157: 846-855.
10. Harrison BJ, Mudge M, Hughes LE,. Recurrence after surgical treatment of hidradenitis suppurativa. Br. Med. J. (Clin. Res. Ed) 1987; 294: 487-489.
11. Alhusayen R, Shear NH,. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say? Am. J. Clin. Dermatol. 2012; 13: 283-291.
12. Boer J, van Gemert MJ,. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J. Am. Acad. Dermatol. 1999; 40: 73-76.
13. Nazary M, van der Zee HH, Prens EP, et al. Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur. J. Pharmacol. 2011; 672: 1-8.
14. Harrison BJ, Read GF, Hughes LE,. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br. J. Surg. 1988; 75: 972-975.
15. Shlyankevich J, Chen AJ, Kim GE, et al. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J. Am. Acad. Dermatol. 2014; 71: 1144-1150.
16. Verdolini R1, Clayton N, Smith A, et al. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J. Eur. Acad. Dermatol. Venereol. 2013; 27: 1101-1108.